Role of hepatic lipase and endothelial lipase in high-density lipoprotein-mediated reverse cholesterol transport

Current Atherosclerosis Reports

Volumn 13, Issue 3, 2011, Pages 257-265

  Annema, Wijtske ^a   Tietge, Uwe J F ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Atherosclerosis; Bile; Cardiovascular disease; Cholesterol; Efflux; Endothelial lipase; Feces; Hepatic lipase; High density lipoproteins; Inflammation; Liver; Macrophage; Macrophage to feces; Phospholipase; Reverse cholesterol transport; Risk; Therapy; Triglycerides

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G1; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; ENDOTHELIAL LIPASE; HIGH DENSITY LIPOPROTEIN; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SCAVENGER RECEPTOR BI; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ATHEROSCLEROSIS; CELL SPECIFICITY; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL LIVER LEVEL; CHOLESTEROL TRANSPORT; DISEASE PREDISPOSITION; ENZYME LOCALIZATION; ENZYME MECHANISM; ENZYME METABOLISM; GENETIC VARIABILITY; HUMAN; INFLAMMATION; LIPOPROTEIN METABOLISM; MACROPHAGE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; TRANSPORT KINETICS;

ANIMALS; ATHEROSCLEROSIS; BIOLOGICAL TRANSPORT; CHOLESTEROL, HDL; DISEASE MODELS, ANIMAL; DRUG DESIGN; ENDOTHELIUM; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LIPASE; LIPID METABOLISM; LIVER; MACROPHAGES; MICE; PHOSPHOLIPASES; POLYMORPHISM, GENETIC;

EID: 79955927693     PISSN: 15233804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11883-011-0175-2     Document Type: Review

References (50)

1. Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005;366:1267-78.
2. Lewis GF, Rader DJ. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res. 2005;96:1221-32. (Pubitemid 40962099)
3. Yasuda T, Ishida T, Rader DJ. Update on the role of endothelial lipase in high-density lipoprotein metabolism, reverse cholesterol transport, and atherosclerosis. Circ J. 2010;74:2263-70.
4. Santamarina-Fojo S, Gonzalez-Navarro H, Freeman L, et al. Hepatic lipase, lipoprotein metabolism, and atherogenesis. Arterioscler Thromb Vasc Biol. 2004;24:1750-4.
5. Jin W, Marchadier D, Rader DJ. Lipases and HDL metabolism. Trends Endocrinol Metab. 2002;13:174-8. (Pubitemid 36733992)
6. Brown RJ, Lagor WR, Sankaranaravanan S, et al. Impact of combined deficiency of hepatic lipase and endothelial lipase on the metabolism of both high-density lipoproteins and apolipoprotein B-containing lipoproteins. Circ Res. 2010;107:357-64. This is the first article determining the role of hepatic lipase and endothelial lipase knockout and hepatic lipase/endothelial lipase double-knockout on macrophage-to-feces reverse cholesterol transport.
7. Ruel IL, Couture P, Cohn JS, et al. Evidence that hepatic lipase deficiency in humans is not associated with proatherogenic changes in HDL composition and metabolism. J Lipid Res. 2004;45:1528-37. (Pubitemid 39006981)
8. Johannsen TH, Kamstrup PR, Andersen RV, et al. Hepatic lipase, genetically elevated high-density lipoprotein, and risk of ischemic cardiovascular disease. J Clin Endocrinol Metab. 2009;94:1264-73.
9. Isaacs A, Sayed-Tabatabaei FA, Njajou OT, et al. The -514C- >T hepatic lipase promoter region polymorphism and plasma lipids: a meta-analysis. J Clin Endocrinol Metab. 2004;89:3858-63. (Pubitemid 39071485)
10. Amigo L, Mardones P, Ferrada C, et al. Biliary lipid secretion, bile acid metabolism, and gallstone formation are not impaired in hepatic lipase-deficient mice. Hepatology. 2003;38:726-34. (Pubitemid 37052159)
11. Barcat D, Amadio A, Palos-Pinto A, et al. Combined hyperlipidemia/ hyperalphalipoproteinemia associated with premature spontaneous atherosclerosis in mice lacking hepatic lipase and low density lipoprotein receptor. Atherosclerosis. 2006;188:347-55. (Pubitemid 44301146)
12. Dichek HL, Qian K, Agrawal N. The bridging function of hepatic lipase clears plasma cholesterol in LDL receptor-deficient "apoB-48-only" and "apoB-100-only" mice. J Lipid Res. 2004;45:551-60.
13. Freeman L, Amar MJ, Shamburek R, et al. Lipolytic and ligandbinding functions of hepatic lipase protect against atherosclerosis in LDL receptor-deficient mice. J Lipid Res. 2007;48:104-13. (Pubitemid 46052902)
14. Qian K, Agrawal N, Dichek HL. Reduced atherosclerosis in chow-fed mice expressing high levels of a catalytically inactive human hepatic lipase. Atherosclerosis. 2007;195:66-74. (Pubitemid 47561947)
15. Mezdour H, Jones R, Dengremont C, et al. Hepatic lipase deficiency increases plasma cholesterol but reduces susceptibility to atherosclerosis in apolipoprotein E-deficient mice. J Biol Chem. 1997;272:13570-5. (Pubitemid 27224787)
16. Karackattu SL, Trigatti B, Krieger M. Hepatic lipase deficiency delays atherosclerosis, myocardial infarction, and cardiac dysfunction and extends lifespan in SR-BI/apolipoprotein E double knockout mice. Arterioscler Thromb Vasc Biol. 2006;26:548-54.
17. Nong Z, Gonzalez-Navarro H, Amar M, et al. Hepatic lipase expression in macrophages contributes to atherosclerosis in apoE-deficient and LCAT-transgenic mice. J Clin Invest. 2003;112:367-78. (Pubitemid 38063765)
18. Hime NJ, Black AS, Bulgrien JJ, Curtiss LK. Leukocyte-derived hepatic lipase increases HDL and decreases en face aortic atherosclerosis in LDLr-/- mice expressing CETP. J Lipid Res. 2008;49:2113-23.
19. Hegele RA, Little JA, Vezina C, et al. Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics. Arterioscler Thromb. 1993;13:720-8.
20. Dugi KA, Brandauer K, Schmidt N, et al. Low hepatic lipase activity is a novel risk factor for coronary artery disease. Circulation. 2001;104:3057-62. (Pubitemid 34014057)
21. Fan YM, Lehtimaki T, Rontu R, et al. The hepatic lipase gene C-480T polymorphism in the development of early coronary atherosclerosis: the Helsinki Sudden Death Study. Eur J Clin Invest. 2007;37:472-7. (Pubitemid 46817347)
22. Andersen RV, Wittrup HH, Tybjaerg-Hansen A, et al. Hepatic lipase mutations, elevated high-density lipoprotein cholesterol, and increased risk of ischemic heart disease: the Copenhagen City Heart Study. J Am Coll Cardiol. 2003;41:1972-82. (Pubitemid 36677118)
23. Ji J, Herbison CE, Mamotte CD, et al. Hepatic lipase gene -514C/T polymorphism and premature coronary heart disease. J Cardiovasc Risk. 2002;9:105-13. (Pubitemid 34553590)
24. Shohet RV, Vega GL, Anwar A, et al. Hepatic lipase (LIPC) promoter polymorphism in men with coronary artery disease. Allele frequency and effects on hepatic lipase activity and plasma HDL-C concentrations. Arterioscler Thromb Vasc Biol. 1999;19:1975-8.
25. Rundek T, Elkind MS, Pittman J, et al. Carotid intima-media thickness is associated with allelic variants of stromelysin-1, interleukin-6, and hepatic lipase genes: the Northern Manhattan Prospective Cohort Study. Stroke. 2002;33:1420-3. (Pubitemid 34517070)
26. Hirata K, Dichek HL, Cioffi JA, et al. Cloning of a unique lipase from endothelial cells extends the lipase gene family. J Biol Chem. 1999;274:14170-5.
27. Jaye M, Lynch KJ, Krawiec J, et al. A novel endothelial-derived lipase that modulates HDL metabolism. Nat Genet. 1999;21: 424-8. (Pubitemid 29159582)
28. Nijstad N, Wiersma H, Gautier T, et al. Scavenger receptor BI-mediated selective uptake is required for the remodeling of high density lipoprotein by endothelial lipase. J Biol Chem. 2009;284:6093-100. This is a comprehensive study including HDL kinetics to demonstrate the complex interaction between EL, HDL, and the SR-BI.
29. Maugeais C, Tietge UJF, Broedl UC, et al. Dose-dependent acceleration of high-density lipoprotein catabolism by endothelial lipase. Circulation. 2003;108:2121-6. (Pubitemid 37337589)
30. Wiersma H, Gatti A, Nijstad N, et al. Hepatic SR-BI, not endothelial lipase, expression determines biliary cholesterol secretion in mice. J Lipid Res. 2009;50:1571-80.
31. Badellino KO, Wolfe ML, Reilly MP, Rader DJ. Endothelial lipase concentrations are increased in metabolic syndrome and associated with coronary atherosclerosis. PLoS Med. 2006;3:e22.
32. Yamakawa-Kobayashi K, Yanagi H, Endo K, et al. Relationship between serum HDL-C levels and common genetic variants of the endothelial lipase gene in Japanese school-aged children. Hum Genet. 2003;113:311-5. (Pubitemid 37059113)
33. Mank-Seymour AR, Durham KL, Thompson JF, et al. Association between single-nucleotide polymorphisms in the endothelial lipase (LIPG) gene and high-density lipoprotein cholesterol levels. Biochim Biophys Acta. 2004;1636:40-6. (Pubitemid 38231003)
34. Edmondson AC, Brown RJ, Kathiresan S, et al. Loss-of-function variants in endothelial lipase are a cause of elevated HDL cholesterol in humans. J Clin Invest. 2009;119:1042-50. This is an important study demonstrating that endothelial lipase is a negative regulator of HDL plasma levels in humans using an experimental approach that combines human genetics with in vitro work and proof-ofconcept studies in experimental animals.
35. Brown RJ, Edmondson AC, Griffon N, et al. A naturally occurring variant of endothelial lipase associated with elevated HDL exhibits impaired synthesis. J Lipid Res. 2009;50:1910-6.
36. Paradis ME, Couture P, Bosse Y, et al. The T111I mutation in the EL gene modulates the impact of dietary fat on the HDL profile in women. J Lipid Res. 2003;44:1902-8. (Pubitemid 37356662)
37. Halverstadt A, Phares DA, Ferrell RE, et al. High-density lipoprotein-cholesterol, its subfractions, and responses to exercise training are dependent on endothelial lipase genotype. Metabolism. 2003;52:1505-11. (Pubitemid 37461123)
38. Qiu G, Hill JS. Endothelial lipase promotes apolipoprotein AI-mediated cholesterol efflux in THP-1 macrophages. Arterioscler Thromb Vasc Biol. 2009;29:84-91.
39. Gauster M, Oskolkova OV, Innerlohinger J, et al. Endothelial lipase-modified high-density lipoprotein exhibits diminished ability to mediate SR-BI (scavenger receptor B type I)-dependent free-cholesterol efflux. Biochem J. 2004;382:75-82. (Pubitemid 39141568)
40. Yancey PG, Kawashiri MA, Moore R, et al. In vivo modulation of HDL phospholipid has opposing effects on SR-BI- and ABCA1-mediated cholesterol efflux. J Lipid Res. 2004;45:337-46.
41. Strauss JG, Zimmermann R, Hrzenjak A, et al. Endothelial cell-derived lipase mediates uptake and binding of high-density lipoprotein (HDL) particles and the selective uptake of HDL-associated cholesterol esters independent of its enzymic activity. Biochem J. 2002;368:69-79. (Pubitemid 35463410)
42. Jin W, Wang X, Millar JS, et al. Hepatic proprotein convertases modulate HDL metabolism. Cell Metab. 2007;6:129-36. (Pubitemid 47189092)
43. Ishida T, Choi SY, Kundu RK, et al. Endothelial lipase modulates susceptibility to atherosclerosis in apolipoprotein-E-deficient mice. J Biol Chem. 2004;279:45085-92. (Pubitemid 39430923)
44. Ko KW, Paul A, Ma K, et al. Endothelial lipase modulates HDL but has no effect on atherosclerosis development in apoE-/- and LDLR-/- mice. J Lipid Res. 2005;46:2586-94. (Pubitemid 43107470)
45. van der Giet M, Tolle M, Pratico D, et al. Increased type IIA secretory phospholipase A(2) expression contributes to oxidative stress in end-stage renal disease. J Mol Med. 2010;88:75-83.
46. Fujii H, Fukuda A, Tanaka M, et al. Putative role of endothelial lipase in dialysis patients with hypoalbuminemia and inflammation. Am J Nephrol. 2008;28:974-81.
47. Shimizu M, Kanazawa K, Hirata K, et al. Endothelial lipase gene polymorphism is associated with acute myocardial infarction, independently of high-density lipoprotein-cholesterol levels. Circ J. 2007;71:842-6. (Pubitemid 46833920)
48. Tang NP, Wang LS, Yang L, et al. Protective effect of an endothelial lipase gene variant on coronary artery disease in a Chinese population. J Lipid Res. 2008;49:369-75. (Pubitemid 351213621)
49. Jensen MK, Rimm EB, Mukamal KJ, et al. The T111I variant in the endothelial lipase gene and risk of coronary heart disease in three independent populations. Eur Heart J. 2009;30:1584-9.
50. Vergeer M, Cohn DM, Boekholdt SM, et al. Lack of association between common genetic variation in endothelial lipase (LIPG) and the risk for CAD and DVT. Atherosclerosis. 2010;211:558-64.